Posted: June 2, 2021
The collaborative project is partnered with CQDM, Simon Fraser University, Amgen, Merck, and Servier.
GlycoNet is delighted to announce that Network Investigator Dr. Robert Britton from Simon Fraser University has received a major multi-year investment from CQDM to develop novel carbohydrate-derived molecules to accelerate drug discovery and manufacturing. This project, partly supported by GlycoNet, is in partnership with three pharmaceutical companies: Amgen Canada, Merck Canada, and Servier Canada. Read the full announcement on CQDM’s news page.
Réseau Canadien de la Glycomique
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.